CN1737112A - A kind of composing type Pichi strain and construction process thereof - Google Patents
A kind of composing type Pichi strain and construction process thereof Download PDFInfo
- Publication number
- CN1737112A CN1737112A CN 200510028752 CN200510028752A CN1737112A CN 1737112 A CN1737112 A CN 1737112A CN 200510028752 CN200510028752 CN 200510028752 CN 200510028752 A CN200510028752 A CN 200510028752A CN 1737112 A CN1737112 A CN 1737112A
- Authority
- CN
- China
- Prior art keywords
- recombinant plasmid
- gene
- bacterial strain
- recombinant
- plasmid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Abstract
The invention discloses a kind of composing type pichia spp recombinant bacterial strain of the D-of expression amino-acid oxidase, this bacterial strain transforms recombinant plasmid pMMZY03, this recombinant plasmid is promotor with the glyceraldehyde 3-phosphate dehydrogenase gene, and contain daao gene, group ammonia alcohol dehydrogenase gene and kalamycin resistance gene.The invention also discloses the construction process of the composing type pichia spp recombinant bacterial strain of described expression D-amino-acid oxidase.Produce bacterial strain with existing known D-amino-acid oxidase and compare, bacterial strain of the present invention has the advantage that the production time shortens, and has avoided the difficult controlling factor of methanol induction in the fermenting process.
Description
Technical field
The present invention relates to genetic engineering bacterium and microbial fermentation field, specifically, is composing type Pichi strain and the construction process thereof about a kind of D-of expression amino-acid oxidase.
Background technology
D-amino-acid oxidase (D-Amino Acid Oxidase, DAO, EC 1.4.3.3) be a kind of be the typical flavoprotein enzyme of prothetic group with flavin adenine dinucleotide (FAD), its catalysis D type amino-acid oxidase deamination reaction, generate corresponding ketone acid and ammonia, and be accompanied by a part hydrogen reduction, and discharge hydrogen peroxide.Produce in 7-amino acid Cephalosporanic acid (7-ACA) technology at two step enzyme methods, DAO is used to transform the first step reaction of cephalosporin (CPC).
Pichia pastoris phaff has become a kind of main eukaryotic microorganisms expression system (Cregg JM., Vedvick TS., Raschke WC.Bio/Technology.11:905-910,1993).Pichia spp can high density fermentation, and the promotor that integrated plasmid is commonly used in the pichia yeast expression system is alcohol oxidase promotor (Alcohol oxidasel promoter, P
AOX1) and glyceraldehyde 3-phosphate dehydrogenase promotor (Glyceraldehyde-3-phosphate dehydrogenase, P
GAP).
The methanol evoked pichia pastoris bacterium can be expressed DAO (the Yu J in trigonopsis variabilis source, Yang S, Yuan ZY.J.Mol.Catal B-Enzym.18:291-297,2002), still, the evoked pichia pastoris bacterium needs to add methanol induction during the fermentation, and induce the condition control more complicated of process, in addition, fermentation time is relatively also long, and enzyme activity peaks needs about 40 hours usually.
Summary of the invention
Purpose of the present invention just is to overcome the existing above-mentioned shortcoming and defect of expressing the methanol evoked pichia pastoris bacterium of D-amino-acid oxidase (DAO), thereby the composing type pichia pastoris gene engineering bacterial strain of a kind of DAO of expression is provided.
Another object of the present invention is to provide the construction process of the composing type Pichiapastoris expression strain of a kind of above-mentioned expression DAO.
The composing type Pichiapastoris expression strain of expression DAO of the present invention transforms recombinant plasmid pMMZY03, this recombinant plasmid is a promotor with the glyceraldehyde 3-phosphate dehydrogenase gene, and contains daao gene, group ammonia alcohol dehydrogenase gene and kanamycin gene.
The construction process of composing type pichia spp recombinant bacterial strain of the present invention may further comprise the steps:
A, digested plasmid plasmid pPIC3.5k reclaim the fragment that contains kanamycin gene and group ammonia alcohol dehydrogenase gene; Digested plasmid pGAPZA reclaims the fragment that contains glyceraldehyde 3-phosphate dehydrogenase gene; Ligase enzyme connects above-mentioned two fragments and obtains recombinant plasmid pPICGAP;
Be connected with the T4 ligase enzyme with DAO gene (HDAO) fragment that has the Histidine purification tag behind B, the recombinant plasmid pPICGAP linearization for enzyme restriction, obtain recombinant plasmid pMMZY03;
C, recombinant plasmid pMMZY03 electric shock is transformed in the pichia spp host bacterium, is built into the composing type pichia spp recombinant bacterial strain of expressing the D-amino-acid oxidase.
Produce bacterial strain with DAO well known in the prior art and compare, the expression strain of the reorganization DAO of band Histidine purification tag of the present invention reaches the required fermentation time of identical fermentation unit and shortens dramatically (being about 1/3), and does not need methanol induction.Therefore have very remarkable advantages aborning, for example the time is short, energy consumption is low, fermenting process control is simple relatively etc.
The new integrative vector promotor that makes up is a glyceraldehyde 3-phosphate dehydrogenase gene.Compare with commercial same type carrier, contain group ammonia alcohol dehydrogenase gene (HIS4) in the carrier, avoided high price microbiotic Zeocin to use simultaneously.
Description of drawings
Fig. 1 is the structure schema of the integrated plasmid pMMZY03 of express recombinant trigonopsis variabilis DAO in the composing type pichia spp.
Embodiment
The invention will be further described below in conjunction with embodiment.Should be understood that following examples only to be used to the present invention is described and be not used in the scope of the present invention that limits.
In following examples, dna fragmentation connects, the preparation of plasmid, and chemical conversion imports the host bacterium, and the clone is all with reference to " molecular cloning " (Sambrook, J., Fritsch, E.P., Maniatis, T. (2001) " Molecular Cloning:A LaboratoryManual 3rd ed; " Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
The composing type pichia pastoris phaff bacterial strain MMZY03 of the expression DAO that the present invention is constructed submits Chinese typical culture collection center (CCTCC) preservation on August 9th, 2005, and preserving number is CCTCC M 205088.
Embodiment 1, plasmid construction
1, material:
Plasmid pPIC3.5k:Invitrogen company product, size is 9.0kb, contains kalamycin resistance gene, ampicillin resistance gene, group ammonia alcohol dehydrogenase gene, promotor is the alcohol oxidase gene, and has a plurality of restriction enzyme sites.
Plasmid pGAPZA:Invitrogen company product, size is 2.9kb, contains the Zeocin resistant gene, promotor is a glyceraldehyde 3-phosphate dehydrogenase gene, and has a plurality of restriction enzyme sites.
Plasmid pLHB-3: according to (Liu HB. such as Liu HB, Jiang WH., Yang YL.Cloning, Sequencing andExpression of D-amino acid oxidase gene.Chinese Journal of Biotechnology 15:337-342,1999) method makes up, and size is 6.4kb, contains the DAO gene (HDAO) of band Histidine purification tag, kalamycin resistance gene, promotor are T7lac.
2, method:
As shown in Figure 1, plasmid pPIC3.5k EcoRI single endonuclease digestion uses BglII partially digested again, and the gene fragment of the about 8.0kb of size is reclaimed in rubber tapping, and this fragment contains kanamycin gene and group ammonia alcohol dehydrogenase gene; Glue reclaims the gene fragment of about 0.5kb behind plasmid pGAPZA usefulness EcoRI and the BglII double digestion, and this fragment contains glyceraldehyde 3-phosphate dehydrogenase gene; The T4 ligase enzyme connects above-mentioned two fragments and obtains recombinant plasmid pPICGAP, and this recombinant plasmid promotor is a glyceraldehyde 3-phosphate dehydrogenase gene, contains group ammonia alcohol dehydrogenase gene and kalamycin resistance gene.
Plasmid pPICGAP puts down with the Klenow benefit after using the EcoRI linearizing again, and glue reclaims the fragment that obtains about 8.5kb size; Plasmid pLHB-3 puts down with the Klenow benefit after using NcoI and HindIII double digestion again, obtains the HDAO gene fragment of about 1.2kb; T
4Ligase enzyme connects two gene fragments, obtains recombinant plasmid pMMZY03, and this recombinant plasmid promotor is a glyceraldehyde 3-phosphate dehydrogenase gene, contains the recommbined D-amino acid oxidase gene, group ammonia alcohol dehydrogenase gene and kalamycin resistance gene.
Embodiment 2, plasmid amplification
Plasmid pMMZY03 adopts conventional chemical transformation " reference molecule clone " to be converted into to e. coli host bacteria DH5 α (Takara), the single transformant of picking is inoculated into LB liquid nutrient medium (1% peptone, 0.5% yeast extract paste, 1% sodium-chlor) in, cultivate amplification pMMZY03 plasmid at 37 ℃.
With reference to " molecular cloning ", adopt the plasmid pMMZY03 of alkaline lysis from the intestinal bacteria extracting amplification of embodiment 2, extractive plasmid is selected the linearizing of BspEI single endonuclease digestion for use, and ethanol sedimentation reclaims the about 10 μ g of linearization plasmid, with pichia spp host bacterium GS115 (his
-Mut
+) competent cell 80 μ l change electricity over to after mixing and transform in the cup, place 5min in the ice bath, prepare simultaneously aly not to add the competent cell of linearization plasmid pMMZY03 as negative control.Adopt the Bio-Rad electricity to transform instrument, it is 1.5KV, 25 μ F, 200 Ω that electricity transforms the parameter setting, and electric shock time 4.6ms adds the sorbyl alcohol of 1ml ice bath immediately after electric shock transforms.The electric shock converted product is coated in MD flat board (1.34%YNB, 4 * 10
-5The % vitamin H, 1% glucose, 2% agarose) on, place 28 ℃ of cultivations, grow transformant on the MD flat board after 2-3 days.
Embodiment 4, transformant screening
10 transformants of picking are seeded in the YPD substratum (2% peptone, 1% yeast extract paste, 2% glucose) from the MD flat board, and culture temperature is 30 ℃, and shaking speed is 280rpm, sampling and measuring DAO vigor when being cultured to 24h.
The DAO definition of an enzyme activity unit (U): 37 ℃, under the pH8.5 condition, the per minute oxidative deamination generates the required enzyme amount of 1 μ mol ketone acid.
Adopt colorimetric method for determining DAO vigor (Nilsson.K., Mosbach.K., Appl.Biochem.Biotechnol., 6:293-308,1981), specific as follows:
Add 50mmol/L DL-methionine solution in the testing sample, oscillatory reaction 30min in 37 ℃ of baths, the trichoroacetic acid(TCA) termination reaction of adding 10% with the sodium pyrophosphate buffer solution preparation of 0.1mol/L, pH8.0.With the 2,4 dinitrophenyl hydrazine saturated solution that adds 0.2% after 10 times of the stop buffer dilutions, mixing leaves standstill 10min.Add the NaOH solution of 3mol/L, leave standstill 15min behind the mixing, A is measured in centrifugal back
550Value.
Measure 10 transformants according to the method described above at the DAO of 24h vigor, the result is as shown in table 1 below:
Table 1, DAO vitality test
| Strain number | Time (hr) | DAO vigor (U/L) | Strain number | Time (hr) | DAO vigor (U/L) |
| GAP-1 | 24 | 1875 | GAP-6 | 24 | 1570 |
| GAP-2 | 24 | 1640 | GAP-7 | 24 | 1302 |
| GAP-3 | 24 | 1520 | GAP-8 | 24 | 872 |
| GAP-4 | 24 | 2011 | GAP-9 | 24 | 1102 |
| GAP-5 | 24 | 950 | GAP-10 | 24 | 1320 |
Method by said determination DAO vigor filters out the highest recombinant bacterial strain of DAO expression, called after MMZY03.This bacterial strain has also been submitted Chinese typical culture collection center (CCTCC) preservation on August 9th, 2005, and preserving number is CCTCC M 205088.
Embodiment 5, express the comparison of DAO vigor
Under equal conditions express the comparison of DAO vigor with composing type recombinant pichia yeast strain MMZY03 of the present invention and induction type recombinant pichia yeast strain, YPD substratum (with embodiment 4) is adopted in fermentation, inoculum size is 5%, leavening temperature is 30 ℃, dissolved oxygen maintains about 30%, regulates pH6.0 with ammoniacal liquor in the fermenting process, constantly counts from inoculation, every 1 hour sampling and measuring DAO vigor, the result was as shown in table 2:
Table 2, expression DAO vigor are relatively
| 5 | 8 | 10 | 13 | 15 | 18 | 20 | 25 | 30 | 35 | 40 | 45 | 50 | |
| Composing type | 1000 | 2100 | 3200 | 6321 | 6120 | 5800 | 5100 | 5450 | 5050 | 4987 | 4782 | 3864 | 3298 |
| Induction type | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3450 | 5832 | 7350 | 6212 | 6008 |
By the result of above table 2 as seen, composing type recombinant pichia yeast strain MMZY03 of the present invention (composing type) during from the about 13h of inoculation time fermentation unit reach the highest, be about 6321U/L, by contrast, the DAO fermentation unit reaches the highest about 40h of needs in the induction type recombinant yeast pichia pastoris that uses in the prior art, and the used time is about 3 times of bacterial strain of the present invention.As seen express the D-amino-acid oxidase with composing type pichia spp recombinant bacterial strain of the present invention, not only can avoid the difficult controlling factor of methanol induction in the fermenting process, and enzyme activity only peak need about 13h about, be about 1/3 of existing methanol evoked bacterial strain, thereby shortened fermentation time greatly, reduce energy consumption, and then reduced production cost.
Claims (9)
1, a kind of composing type pichia spp recombinant bacterial strain of expressing the D-amino-acid oxidase, it is characterized in that, described bacterial strain transforms recombinant plasmid pMMZY03, this recombinant plasmid is a promotor with the glyceraldehyde 3-phosphate dehydrogenase gene, and contains daao gene, group ammonia alcohol dehydrogenase gene and kanamycin gene.
2, composing type pichia spp recombinant bacterial strain as claimed in claim 1 is characterized in that, described recombinant plasmid pMMZY03 also has histidine-tagged.
3, composing type pichia spp recombinant bacterial strain as claimed in claim 1 is characterized in that, the preserving number CCTCC M 205088 of described bacterial strain.
4, a kind of construction process of composing type pichia spp recombinant bacterial strain is characterized in that may further comprise the steps:
A, digested plasmid pPIC3.5k reclaim the fragment that contains kanamycin gene and group ammonia alcohol dehydrogenase gene; Digested plasmid pGAPZA reclaims the fragment that contains glyceraldehyde 3-phosphate dehydrogenase gene; Ligase enzyme connects above-mentioned two fragments and obtains recombinant plasmid pPICGAP;
Be connected with the daao gene fragment that has the Histidine purification tag with ligase enzyme behind B, the recombinant plasmid pPICGAP linearization for enzyme restriction, obtain recombinant plasmid pMMZY03;
C, recombinant plasmid pMMZY03 electric shock is transformed in the pichia spp host bacterium, is built into the composing type pichia spp recombinant bacterial strain of expressing the D-amino-acid oxidase.
5, method as claimed in claim 4 is characterized in that, employed ligase enzyme is the T4 ligase enzyme among steps A and the B.
6, method as claimed in claim 4 is characterized in that, linearizing recombinant plasmid pPICGAP described in the step B and the daao gene fragment that has a Histidine purification tag are mended with Klenow earlier before connecting with ligase enzyme and put down.
7, method as claimed in claim 4 is characterized in that, also comprises recombinant plasmid pMMZY03 is imported the step that intestinal bacteria are increased before recombinant plasmid pMMZY03 electric shock is transformed into pichia spp host bacterium.
8, a kind of recombinant plasmid is characterized in that, described recombinant plasmid is promotor with the glyceraldehyde 3-phosphate dehydrogenase gene, and contains daao gene, group ammonia alcohol dehydrogenase gene and kanamycin gene.
9, recombinant plasmid as claimed in claim 4 is characterized in that, described recombinant plasmid has histidine-tagged.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200510028752XA CN100381559C (en) | 2005-08-12 | 2005-08-12 | Constitutive P. pastoris strain and its construction method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200510028752XA CN100381559C (en) | 2005-08-12 | 2005-08-12 | Constitutive P. pastoris strain and its construction method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1737112A true CN1737112A (en) | 2006-02-22 |
| CN100381559C CN100381559C (en) | 2008-04-16 |
Family
ID=36080061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200510028752XA Expired - Fee Related CN100381559C (en) | 2005-08-12 | 2005-08-12 | Constitutive P. pastoris strain and its construction method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100381559C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113322223A (en) * | 2021-06-03 | 2021-08-31 | 重庆市畜牧科学院 | Selenium-enriched yeast genetically engineered bacterium, surface display system thereof and construction method thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1275909B1 (en) * | 1995-03-07 | 1997-10-24 | Mirella Pilone | FRAGMENT OF DNA CODING D-AMINO ACID OXIDASE |
| CN1151261C (en) * | 2001-02-28 | 2004-05-26 | 中国科学院上海植物生理研究所 | Double gene coexpression plasmid, construction method and application thereof |
| CN1141378C (en) * | 2001-11-30 | 2004-03-10 | 中国科学院上海生物化学研究所 | High-efficient expression D-amino acid oxidase methanol yeast, its construction and fermentation method |
| JP4257730B2 (en) * | 2003-08-25 | 2009-04-22 | キッコーマン株式会社 | Acyl CoA oxidase, its gene, recombinant DNA, and method for producing acyl CoA oxidase |
-
2005
- 2005-08-12 CN CNB200510028752XA patent/CN100381559C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113322223A (en) * | 2021-06-03 | 2021-08-31 | 重庆市畜牧科学院 | Selenium-enriched yeast genetically engineered bacterium, surface display system thereof and construction method thereof |
| CN113322223B (en) * | 2021-06-03 | 2023-09-12 | 重庆市畜牧科学院 | Selenium-enriched yeast genetically engineered bacterium, surface display system thereof and construction method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100381559C (en) | 2008-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tanaka et al. | Ethanol production from starch by a coimmobilized mixed culture system of Aspergillus awamori and Zymomonas mobilis | |
| Reimann et al. | Production of 1, 3-propanediol by Clostridium butyricum in continuous culture with cell recycling | |
| Liew et al. | Production of solvent (acetone-butanol-ethanol) in continuous fermentation by Clostridium saccharobutylicum DSM 13864 using gelatinised sago starch as a carbon source | |
| Jeong et al. | Ethanol production by co-fermentation of hexose and pentose from food wastes using Saccharomyces coreanus and Pichia stipitis | |
| JP3348215B2 (en) | Method for producing xylitol | |
| CN104480083A (en) | Lipase, engineering bacterium and preparing methods of the lipase and the engineering bacterium | |
| Skory | Induction of Rhizopus oryzae pyruvate decarboxylase genes | |
| CN100342002C (en) | Secretion type Pichi strain and its construction method | |
| CN100381559C (en) | Constitutive P. pastoris strain and its construction method | |
| CN101613707B (en) | Method for producing glutathione by use of metabolic engineering bacteria | |
| El-Diwany et al. | Effect of some fermentation parameters on ethanol production from beet molasses by Saccharomyces cerevisiae Y-7 | |
| CN101878308B (en) | A process for the preparation of ethanol from starch | |
| US10392624B2 (en) | Gene engineering yeast having saccharification function, method of preparing same, and application of same | |
| Burrill et al. | The inhibitory effect of ethanol on ethanol production by Zymomonas mobilis | |
| CN115058374B (en) | Recombinant zymomonas mobilis for synthesizing acetoin by utilizing pyruvic acid as well as construction method and application thereof | |
| ZHANG et al. | Effect of propanoic acid on ethanol fermentation by Saccharomyces cerevisiae in an ethanol-methane coupled fermentation process | |
| CN108865914B (en) | Recombinant saccharomyces cerevisiae strain capable of degrading lignocellulose and application thereof | |
| CN1385537A (en) | Process for producing adenosylmethionine by metabolic engineering bacteria | |
| CN107236680A (en) | A kind of pichia yeast recombinant bacterium of expression Streptomyces sp. FA1 sources zytase | |
| Lee et al. | A cell retention internal filter reactor for ethanol production using tapioca hydrolysates | |
| CN112852773A (en) | Method for producing D-amino acid oxidase by fermentation | |
| CN108949724B (en) | Novel glucoamylase as well as gene and application thereof | |
| Zoutberg et al. | Solvent production by an aggregate-forming variant of Clostridium butyricum | |
| CN112779174B (en) | Saccharomyces cerevisiae genetically engineered bacterium for knocking out Cln3 gene, construction method and application thereof | |
| CN103451114B (en) | Pichia pastoris engineering bacteria capable of yielding alpha-glucanase and culture method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080416 Termination date: 20120812 |